Cargando…
Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis
Metformin exerts its plasma glucose-lowering therapeutic effect primarily through inhibition of hepatic gluconeogenesis. However, the precise molecular mechanism by which metformin inhibits hepatic gluconeogenesis is still unclear. Although inhibition of mitochondrial complex I is frequently invoked...
Autores principales: | LaMoia, Traci E., Butrico, Gina M., Kalpage, Hasini A., Goedeke, Leigh, Hubbard, Brandon T., Vatner, Daniel F., Gaspar, Rafael C., Zhang, Xian-Man, Cline, Gary W., Nakahara, Keita, Woo, Seungwan, Shimada, Atsuhiro, Hüttemann, Maik, Shulman, Gerald I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916010/ https://www.ncbi.nlm.nih.gov/pubmed/35238637 http://dx.doi.org/10.1073/pnas.2122287119 |
Ejemplares similares
-
Cellular and Molecular Mechanisms of Metformin Action
por: LaMoia, Traci E, et al.
Publicado: (2020) -
Brain-Specific Serine-47 Modification of Cytochrome c Regulates Cytochrome c Oxidase Activity Attenuating ROS Production and Cell Death: Implications for Ischemia/Reperfusion Injury and Akt Signaling
por: Kalpage, Hasini A., et al.
Publicado: (2020) -
Metformin Inhibits Gluconeogenesis by a Redox-Dependent Mechanism In Vivo
por: Madiraju, Anila K., et al.
Publicado: (2018) -
Antihypertensive Effect of Galegine from Biebersteinia heterostemon in Rats
por: Wang, Weien, et al.
Publicado: (2021) -
Tissue- and Condition-Specific Isoforms of Mammalian Cytochrome c Oxidase Subunits: From Function to Human Disease
por: Sinkler, Christopher A., et al.
Publicado: (2017)